Long-term Treatment Study of CDP870 Self-injection in Patients With Active Rheumatoid Arthritis Who Are Participating in the Long-term Treatment Studies (Study 275-08-002 or Study 275-08-004) of CDP870
Clinical trial NCT02586246 · COMPLETED
Trial details
- NCT number
- NCT02586246
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2013-05-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.